Will I Go Completely Blind from ADOA?
At a Glance
Total blindness is extremely rare in Autosomal Dominant Optic Atrophy (ADOA). While the condition causes progressive central vision loss and can lead to legal blindness, it typically spares peripheral vision, allowing most people to maintain functional sight and independence throughout their lives.
In this answer
5 sections
It is completely normal to be afraid of going completely blind when diagnosed with an optic nerve condition. However, for people with Autosomal Dominant Optic Atrophy (ADOA), total blindness (having absolutely zero light perception or living in complete darkness) is extremely rare. While ADOA does cause progressive vision loss, it affects the optic nerve in a specific way that typically protects your peripheral (side) vision. Many patients maintain relatively good functional vision well into their adult lives [1].
Legal Blindness vs. Total Blindness
To understand what to expect with ADOA, it helps to distinguish between two terms that are often confused: “legal blindness” and “total blindness.”
- Legal Blindness: This is a term used by governments to determine eligibility for certain disability services and benefits. In the United States, you are considered legally blind if your central visual acuity is 20/200 or worse in your better-seeing eye (while wearing your best glasses), or if your visual field is restricted to 20 degrees or less. Legal blindness can occur in ADOA, especially as the disease slowly progresses over a lifetime [2]. Being legally blind means you may have significant difficulty with fine-detail tasks like reading small print or driving, but you still have highly usable functional vision.
- Total Blindness (No Light Perception): This means the eyes cannot perceive light at all. Total blindness is exceptionally rare in ADOA. Because of how the condition behaves, the vast majority of patients will never experience complete darkness.
Why ADOA Usually Spares Peripheral Vision
ADOA is an inherited condition caused by genetic changes (most commonly in the OPA1 gene) that affect the retinal ganglion cells—the cells that bundle together to form your optic nerve [3]. The disease typically damages the delicate cells responsible for your central, high-resolution vision and color vision first (often causing blue-yellow color confusion, known medically as tritanopia). This damage creates a blurry or missing area in the middle of your visual field (known as a central scotoma) [4].
However, the nerve cells that manage your peripheral (side) vision are usually much less affected and are typically preserved throughout your life [5]. Because your side vision remains intact, people with ADOA can usually navigate their physical surroundings, walk independently, and recognize movement, even if their central vision eventually drops below the legal blindness threshold.
The Highly Variable Course of ADOA
Vision loss in ADOA is notorious for being unpredictable, making it difficult to give a one-size-fits-all timeline [6]. Even within the same family, two people with the exact same genetic mutation might have very different levels of vision [7].
- Childhood Onset: Vision loss typically begins in early childhood (often diagnosed around ages 4 to 6) and slowly worsens over time [2]. Young children rarely self-report vision loss because it is their “normal,” so parents or teachers are often the first to notice.
- Adulthood: Some cases are so mild that they are not caught until adulthood. While visual acuity can slowly decline over decades, many individuals maintain functional vision into late middle age or beyond [1][3].
Because everyone’s journey is unique, your eye care team will regularly monitor your best corrected visual acuity (how well you see using the best possible glasses prescription) and use visual field tests to track exactly how the condition is affecting your optic nerve over time [4].
Beyond the Eyes: “ADOA Plus”
While ADOA primarily affects the optic nerve, up to 20% of patients experience a variation called ADOA plus syndrome [8]. In addition to vision changes, ADOA plus can cause other symptoms throughout the body, most notably sensorineural hearing loss (damage to the inner ear), muscle weakness, or nerve issues [9]. Because of this, comprehensive care involves more than just eye exams—routine hearing tests and neurological evaluations are an important part of managing the condition.
Next Steps and Living with ADOA
Currently, there are no medical cures, eye drops, or surgeries that can reverse optic nerve damage from ADOA. However, you are not powerless.
- Low Vision Rehabilitation: Working with a low vision specialist or occupational therapist is highly effective. They can introduce you to specialized magnifiers, text-to-speech technology, and everyday strategies that maximize the vision you do have.
- Genetic Counseling: Because ADOA is an inherited condition (“autosomal dominant” means there is a 50% chance of passing it to a child), meeting with a genetic counselor is crucial. They can help you understand exactly what the diagnosis means for your relatives and future children.
Common questions in this guide
Does ADOA cause total blindness?
What is the difference between legal blindness and total blindness in ADOA?
Why does ADOA affect my central vision but not my side vision?
What is ADOA plus syndrome?
Are there treatments to reverse vision loss from ADOA?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my current visual acuity, and how close am I to the threshold for legal blindness?
- 2.Looking at my visual field tests, how well is my peripheral vision being preserved?
- 3.Should I be scheduled for a formal audiology (hearing) test to screen for ADOA plus syndrome?
- 4.Can you refer me to a low-vision specialist to help me maximize the vision I still have?
- 5.How can I get a referral for genetic counseling to discuss how this diagnosis might affect my children or family members?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (9)
- 1
Case of autosomal dominant optic atrophy with relatively good visual function.
Tachibana M, Hayashi T, Igawa Y, et al.
BMC ophthalmology 2025; (25(1)):443 doi:10.1186/s12886-025-04276-5.
PMID: 40751186 - 2
Genetic and Clinical Analyses of DOA and LHON in 304 Chinese Patients with Suspected Childhood-Onset Hereditary Optic Neuropathy.
Li Y, Li J, Jia X, et al.
PloS one 2017; (12(1)):e0170090 doi:10.1371/journal.pone.0170090.
PMID: 28081242 - 3
ATPase Domain AFG3L2 Mutations Alter OPA1 Processing and Cause Optic Neuropathy.
Caporali L, Magri S, Legati A, et al.
Annals of neurology 2020; (88(1)):18-32 doi:10.1002/ana.25723.
PMID: 32219868 - 4
Short Wavelength Automated Perimetry, Standard Automated Perimetry, and Optical Coherence Tomography in Dominant Optic Atrophy.
Lombardo M, Cusumano A, Mancino R, et al.
Journal of clinical medicine 2024; (13(7)) doi:10.3390/jcm13071971.
PMID: 38610740 - 5
A novel AFG3L2 mutation close to AAA domain leads to aberrant OMA1 and OPA1 processing in a family with optic atrophy.
Baderna V, Schultz J, Kearns LS, et al.
Acta neuropathologica communications 2020; (8(1)):93 doi:10.1186/s40478-020-00975-w.
PMID: 32600459 - 6
Increased steroidogenesis promotes early-onset and severe vision loss in females with OPA1 dominant optic atrophy.
Sarzi E, Seveno M, Angebault C, et al.
Human molecular genetics 2016; (25(12)):2539-2551 doi:10.1093/hmg/ddw117.
PMID: 27260406 - 7
Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy.
Ham M, Han J, Osann K, et al.
Mitochondrion 2019; (46()):262-269 doi:10.1016/j.mito.2018.07.006.
PMID: 30165240 - 8
A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family.
Ahmad KE, Davis RL, Sue CM
Journal of neurology 2015; (262(10)):2323-8 doi:10.1007/s00415-015-7849-6.
PMID: 26194196 - 9
Autosomal dominant optic atrophy plus due to the novel OPA1 variant c.1463G>C.
Finsterer J, Laccone F
Metabolic brain disease 2019; (34(4)):1023-1027 doi:10.1007/s11011-019-00425-0.
PMID: 31152339
This page provides educational information about vision loss progression in ADOA. It is not a substitute for professional medical advice, and you should always consult your eye care team or genetic counselor for personalized guidance.
Get notified when new evidence is published on Autosomal dominant optic atrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.